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ABSTRACT
Background: Estimates of the impact of HIV in countries
with generalised epidemics are generally based on
antenatal clinic surveillance data collected over time. In an
attempt to obtain geographically more representative
estimates of HIV prevalence, many countries are now also
conducting national population-based surveys in which
HIV testing is included. We compare adult HIV prevalence
estimates from antenatal clinic surveillance to those from
national population-based surveys to assess the implica-
tions for calibrating surveillance data.
Methods: HIV prevalence estimates derived from fitting
prevalence curves to antenatal clinic surveillance data are
statistically compared to prevalence from national
population-based surveys using data from 26 countries
with generalised epidemics for the year in which the
survey was conducted. Appropriate transformations are
applied to inform the correction factors needed to adjust
prevalence in countries where population-based surveys
have not been conducted.
Results: HIV prevalence derived from antenatal
clinic surveillance data generally overestimate
population-based survey prevalence by about 20%
(95% confidence interval: 10% to 30%) in both urban
and rural areas.
Conclusions: In countries where national population-
based HIV surveys have been conducted, survey
estimates of HIV prevalence (adjusted for potential survey
biases as appropriate) can be used directly to calibrate
antenatal clinic surveillance data. In countries where
national HIV surveys have not been conducted, HIV
prevalence derived from antenatal clinic surveillance data
should be multiplied by about 0.8 to adjust for
overestimation.
Facility-based sentinel surveillance of HIV has been
recommended for monitoring the HIV epidemic
since the mid-1980s, mainly because of easy access
to people attending public health facilities.
1 In
countries with generalised HIV epidemics, defined
by UNAIDS and the World Health Organization as
countries where adult prevalence is firmly estab-
lished in the general population and transmission
occurs mostly through heterosexual sex,
2 annual
HIV surveillance among pregnant women attend-
ing public-sector antenatal clinics has over time
become the primary source of data on the spread of
HIV.
3
Concerns about the limitations associated with
antenatal clinic surveillance have in recent years
led to an increase in the number of countries
conducting large national population-based sur-
veys in which HIV testing has been included.
These surveys are geographically more representa-
tive than antenatal clinic surveillance and include
samples from urban and rural areas, men and
women and different age groups.
Both sentinel surveillance and population-based
surveys have strengths and weaknesses, but taken
together provide complementary information and
can provide a clearer picture of both overall trends
and geographical distribution of HIV in a country.
4
While national population-based surveys provide
better coverage of the general population, sentinel
surveillance provide important information on
prevalence trends over time.
UNAIDS/WHO estimates of national adult
HIV prevalence and the demographic impact of
HIV in countries with generalised epidemics have
been based on prevalence data collected over time
from pregnant women attending antenatal
clinics.
56 Because of differences in prevalence
between urban and rural areas, country-specific
prevalence is often estimated separately for
urban and rural areas, and then combined to
obtain a national, weighted estimate of adult
prevalence.
7 Historically, the prevalence curve for
non-urban areas was adjusted downward by 20%
because surveillance systems often did not cover
rural areas well, and it was assumed that HIV
prevalence was lower in those areas that were
excluded from surveillance.
5 In more recent years,
in countries where national population-based
surveys have been conducted, prevalence curves
fitted to antenatal clinic surveillance data have
been calibrated so that the fitted prevalence agrees
with the reported population-based survey pre-
valence estimate for the year in which the survey
was conducted.
8
In addition to using population-based survey
estimates of adult HIV prevalence to calibrate
adult prevalence curves fitted to antenatal clinic
data in countries where such population-based
surveys have been conducted, a comparison of
these estimates can also be used to inform the
adjustment factor needed to correct for potential
surveillance bias in countries where national
population-based surveys have not been con-
ducted. In this paper we compare adult HIV
prevalence estimates from national population-
based surveys to those derived from antenatal
clinic surveillance to assess the implications for
calibrating surveillance data.
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Antenatal clinic surveillance
HIV surveillance has been carried out among women attending
antenatal clinics in more than 115 countries worldwide.
3 In
2006, it was estimated that more than 600 sites in sub-Saharan
Africa have been included in surveillance efforts on a regular
basis.
9 These sentinel surveys are usually conducted annually or
bi-annually around the same time of the year and involve
anonymous, unlinked sampling of blood from pregnant women
attending selected antenatal clinics in the public health sector.
The main strength of antenatal clinic surveillance is that it
provides ready and easy access to a cross-section of sexually
active pregnant women from the general population, and it can
be used to assess trends in the epidemic over time. In generalised
epidemics, HIV prevalence among pregnant women has been
considered a good approximation of prevalence among sexually
active men and women aged 15–49 years.
10 In several countries
geographical coverage of HIV surveillance systems has expanded
over time according to the needs and available resources, often
improving the representativeness of samples.
A major limitation of sentinel surveillance systems, however,
is limited geographical coverage because sampling is often not
representative of smaller and more remote areas in a country.
4
Antenatal clinic surveillance provides information on women of
reproductive age, while estimates for men are based on
assumptions about the ratio of male-to-female prevalence
derived from community surveys. Furthermore, women attend-
ing public antenatal clinics might not be representative of all
pregnant women in a country, because some women may
receive antenatal care in private clinics, some at home through
outreach services and others may receive no professional care.
The World Health Organization in 2005 estimated that
antenatal care coverage (with at least one antenatal care contact
during pregnancy, including care received at private clinics and
through outreach services) varied from 27% to 99% (median
across 34 countries of 85%) in sub-Saharan Africa.
11 While
sentinel surveillance provides the best source of data on
prevalence trends in a country, analysis of these data should
be done carefully because of changing geographical surveillance
coverage over time, and because the composition of women
attending antenatal clinics may change over time as fertility
rates change. Furthermore, the quality of surveillance may vary
across regions and over time depending on available resources.
National population-based surveys
Since 2000, more than 25 countries in sub-Saharan Africa have
conducted national population-based household surveys, includ-
ing demographic and health surveys (DHS) and AIDS indicator
surveys (AIS), in which biological specimens for HIV testing
have been collected at a national level (www.measuredhs.com).
These surveys include large nationally representative probability
samples of adult men and women and generally use dried blood
spots for collecting specimens for HIV testing. The main
strength of population-based surveys is that they can provide
estimates of HIV prevalence in the general population as well as
for different subgroups in different geographical locations, for
women and men, and for people in different age groups.
4
Another major strength is that HIV serostatus can be linked
to social, behavioural and other biomedical information,
providing the opportunity to study the dynamics of the
epidemic in more detail.
The main limitation of population-based surveys is potential
bias arising from refusal of study subjects to participate in the
survey or to have blood taken for HIV testing, as well as absence
of study subjects from the household at the time of the survey.
Furthermore, sampling from households in population-based
surveys may not adequately represent high-risk non-household
population groups and mobile populations. In countries with
concentrated or low-level epidemics, population-based surveys
might therefore underestimate HIV prevalence and household
surveys may be less useful in determining national prevalence in
these settings.
41 2A further limitation is that population-based
household surveys can generally not be conducted frequently
because they are logistically difficult and expensive to carry out,
and have therefore not been used to assess epidemic trends over
time.
Using population-based surveys as ‘‘gold standard’’ for
estimating adult HIV prevalence
The reliability of HIV prevalence estimates obtained from
population-based household surveys depends on sound survey
and sampling methodology, including taking representative
samples of the adult population in relevant subgroups, ensuring
high quality of data and specimen collection and employing
sound laboratory methods for HIV testing while maintaining
high ethical standards. A major challenge in population-based
surveys is to minimise the level of non-response, either due to
refusal to participate or due to absence of household members at
the time of the survey. Mishra and colleagues
13 studied the
impact of non-response on HIV prevalence in national popula-
tion-based surveys in 14 countries and showed that non-
response did not significantly bias HIV estimates. Even though
the HIV prevalence among the non-responders in the surveys
was predicted to be higher than those who were tested for HIV,
the overall effects of non-response on observed prevalence were
small and insignificant. In another analysis of data from
population-based surveys conducted in 20 countries with
generalised epidemics in sub-Saharan Africa, Calleja et al
9
confirmed that for non-response to have a significant effect
on observed HIV prevalence, either the non-response rate or the
risk of HIV prevalence among non-responders relative to survey
respondents, or both, has to be substantial.
A further concern with household surveys is that they
exclude mobile populations and people not living in households
(for example, people living in hostels, military or police barracks,
refugee camps, brothels and prisons) among whom HIV
prevalence is likely to be higher than among people living in
households. Excluding these groups could lead to an under-
estimate of national prevalence. Mishra et al,
13 based on an
evaluation of potential bias due to exclusion of non-household
groups in population-based surveys, conclude that the effect of
excluding non-household population groups on the national
estimates of HIV prevalence obtained from a household sample
is likely to be small in countries with generalised epidemics.
Moreover, given the small proportion of the non-household
population relative to the total population, even in countries
with concentrated epidemics, HIV prevalence among the non-
household population needs to be orders of magnitude higher
than among the household population for exclusion of non-
household groups to have a significant effect on national
prevalence based on the household population.
The response rates in the population-based surveys used in
this paper were generally high, with the exception of South
Africa and Botswana where the national response rate was
below 70%,
14 15 and the Lilongwe district in Malawi where the
response rate was 38%.
16 Urban and rural comparisons could,
however, not be made between the survey and antenatal clinic-
based prevalence estimates for Botswana and South Africa, and
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Malawi, the HIV prevalence for the Lilongwe district as well
as for the country as a whole was adjusted for the effect of non-
response.
16 In all other countries used in this analysis, the survey
response rate was greater than 70% among men and women
combined,
13 methodology and laboratory procedures were
sound and it was assumed that the population-based surveys
provided high quality, reliable and representative national
estimates of HIV prevalence.
Fitting a curve to national antenatal clinic data over time
The Estimation and Projection Package (EPP) version 2007
17 was
used to fit prevalence curves to antenatal clinic surveillance data
collected over time (1985-2007) by national AIDS councils or
ministries of health (epidemiological fact sheets, available at
www.who.int). Using a maximum likelihood procedure, the
EPP model fits curves to HIV epidemics by varying four
parameters
78 ; the rate of growth of the epidemic (r); the start
year of the epidemic (t0); the fraction of the population
considered to be at risk of infection at the start of the epidemic
(f0); and a behavioural response parameter which determines the
final epidemic prevalence (w).
Surveillance systems in most countries have expanded over
time, often into areas or settings with lower prevalence than
those initially and deliberately selected because of known HIV
cases in such areas. In order to deal with such expanding
surveillance systems, EPP has incorporated a level fitting
procedure, which is described in detail elsewhere.
8 The
procedure is based on the approximation that, while there are
variations in absolute prevalence levels from one site to the
next, the overall trend of rising and falling prevalence is the
same throughout the region being modelled—that is, that all
sites in a particular region are assumed to follow similar
prevalence patterns over time.
Comparison of antenatal clinic and population-based survey
estimates of HIV prevalence
For countries with generalised epidemics, published reports of
national population-based surveys since 2000, including the
demographic and health surveys (DHS) and AIDS indicator
surveys (AIS) (available at www.measuredhs.com) that
included HIV prevalence measurement, were reviewed. In
addition, three preliminary reports of DHS conducted in
2006–7 in Central African Republic,
18 Liberia
19 and Swaziland
20
were reviewed. HIV prevalence among adults (aged 15–49 years)
Figure 1 Ratio of population-based
adult HIV prevalence to prevalence
derived from antenatal clinic data for the
year in which the survey was conducted,
by country and region. The national adult
HIV prevalence from population-based
surveys is given in parenthesis for each
country.
Figure 2 Adjusted antenatal clinic-
derived prevalence using either probit
transformations or the median prevalence
ratio (survey: antenatal clinic), plotted
against the ‘‘gold standard’’ population-
based survey prevalence for 26 countries
with generalised epidemics.
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surveys where the level of non-response could potentially bias
HIV estimates, specifically in Ethiopia
21 and Malawi,
16 HIV
prevalence among survey participants was adjusted according to
the predicted prevalence among the non-responders, and the
adjusted prevalence estimates were used in the analysis.
For those countries in which national population-based
surveys have been conducted, an independent estimate of adult
HIV prevalence was derived from fitting a curve using EPP to
available antenatal clinic prevalence data over time. For
comparison purposes the unadjusted, fitted estimate of HIV
prevalence was recorded for urban and rural areas for the same
year in which the survey was conducted. We used the fitted
prevalence estimates rather than the median prevalence across
surveillance sites because the fitted curve takes account of
variation in estimates and is based on an average over time
rather than on the prevalence recorded for one year only. In
addition, some countries do not conduct antenatal clinic
surveillance every year and for several countries antenatal clinic
surveillance was not done in the same year as the survey.
However, with EPP a fitted estimate could be obtained for each
year, including the year in which the survey was conducted.
The two sets of prevalence estimates were compared for 26
countries with generalised epidemics in which national surveys
have been conducted and for which urban and rural estimates
were available, assuming the prevalence from population-based
surveys to be the ‘‘gold standard’’. The ratio of population-
based survey to antenatal clinic-based prevalence was calculated
for each of the 26 countries for the year in which the survey was
conducted. The medians, means and standard errors of the sets
of urban and rural ratios were then calculated. To standardise
the variance in the data, we applied a probit transformation
22 to
population-based and antenatal clinic derived prevalence esti-
mates, of the form Y9 = W
-1(p), where Y9 is the probit-
transformed value, p is the prevalence, and W
-1 is the inverse of
the cumulative standard normal distribution. We then calcu-
lated the median of the differences in probit-transformed
prevalences. These median values (for the unadjusted survey:
antenatal clinic prevalence ratio and for the probit-transformed
prevalence difference across countries) were then used to inform
the adjustment factors needed to correct antenatal clinic-based
prevalence estimates in countries.
The two correction factors (based on the median ratio or the
probit-transformed median difference) were then applied to the
antenatal clinic-based estimates of prevalence for each country
to determine how well the adjusted estimates agree with the
‘‘gold standard’’ population-based survey prevalence.
RESULTS
Table 1 shows the comparison between HIV prevalence in
urban and rural areas estimated from population-based surveys
and derived from antenatal clinic data for 26 countries with
generalised epidemics in which population surveys have been
conducted, for the year in which the survey was conducted. The
majority of countries (24) were from sub-Saharan Africa, with
two additional countries (Haiti and the Dominican Republic)
from the Caribbean. For three countries in southern Africa,
estimates of adult (age 15–49 years) HIV prevalence were not
Table 2 Antenatal clinic (ANC) surveillance-based estimates of HIV prevalence adjusted using either the median of the survey to antenatal clinic-
based prevalence ratios, or the median of the probit-transformed prevalence difference; compared to the ‘‘gold standard’’ population-based survey
prevalence
Country
Urban Rural
National survey
adult HIV prev
Adjusted ANC
prevalence using
median ratio
Adjusted ANC
prevalence using
probit transforms
National survey
adult HIV
prevalence
Adjusted ANC prevalence
using median ratio
Adjusted ANC
prevalence using probit
transforms
Lesotho 29.1 26.6 28.5 21.9 19.8 21.5
Malawi 18.3 15.2 15.7 11.3 10.4 11.0
Zambia 23.1 21.7 22.9 10.8 10.3 10.9
Zimbabwe 18.9 18.0 18.9 17.6 15.3 16.4
Burundi 9.4 9.7 9.8 2.5 2.0 2.0
Ethiopia 5.6 8.6 8.7 0.7 1.6 1.5
Kenya 10.0 9.1 9.1 5.6 7.0 7.2
Rwanda 7.3 4.9 4.7 2.2 2.2 2.2
Tanzania 10.9 9.2 9.3 5.3 4.5 4.6
Uganda 10.1 7.6 7.6 5.7 3.5 3.5
Benin 1.7 1.6 1.5 0.9 1.0 0.9
Burkina Faso 3.6 3.2 3.1 1.3 1.3 1.3
Cameroon 6.7 6.8 6.8 4.0 5.5 5.7
Central African
Republic
8.3 11.0 11.2 4.7 12.5 13.3
Chad 7.0 4.0 3.9 2.3 2.3 2.3
Cote d’Ivoire 5.4 5.5 5.4 4.1 3.7 3.8
Equatorial Guinea 3.3 2.6 2.4 3.1
Ghana 2.3 2.9 2.7 2.0 2.7 2.7
Guinea 2.4 4.1 3.9 1.0 2.6 2.6
Liberia 2.5 4.0 3.8 0.8
Mali 2.2 3.0 2.8 1.5 2.1 2.1
Niger 2.1 2.1 1.9 0.6 1.1 1.0
Senegal 0.7 1.2 1.1 0.7 1.1 1.1
Sierra Leone 2.1 3.5 3.3 1.3
Haiti 2.3 4.2 4.1 2.0 1.9 1.8
Dominican Republic 0.9 1.6 1.5 1.2
Supplement
Sex Transm Infect 2008;84(Suppl I):i17–i23. doi:10.1136/sti.2008.030452 i21available for urban and rural areas, either from the population-
based survey (Botswana) or from antenatal clinic surveillance
over time (South Africa and Swaziland). In Liberia, Sierra Leone,
Equatorial Guinea and the Dominican Republic, antenatal clinic
surveillance covered urban areas, but not rural areas.
The median ratio of population-based survey to antenatal
clinic-derived prevalence estimates across countries was 0.82
(interquartile range: 0.55–0.97) for urban and 0.81 (interquartile
range: 0.58–0.89) for rural areas. Corresponding mean ratios
were 0.80 (95% CI: 0.69 to 0.90) and 0.74 (95% CI: 0.62 to 0.85),
respectively.
For a majority of the countries, the prevalence ratio in both
urban and rural areas was smaller than 1, indicating that
estimated adult HIV prevalence derived from antenatal clinic
surveillance almost always overestimates adult prevalence in
countries with generalised epidemics (fig 1). The exceptions
were Rwanda, Chad and Equatorial Guinea, where urban
prevalence from the population-based surveys was higher than
the corresponding prevalence derived from antenatal clinic
surveillance, and in Uganda, where both urban and rural
prevalence were higher in the population-based survey than
those derived from antenatal clinic surveillance. In both Chad
and Equatorial Guinea, antenatal clinic surveillance systems are
generally weak and the projections were based on limited data.
Prevalence ratios in countries with a higher adult prevalence,
notably in southern and East Africa, were in general closer to 1
than in countries in West and Central Africa and in the
Caribbean with a lower national prevalence. Median prevalence
ratios (population-based survey: antenatal clinic) are shown for
the four regions in figure 1, with a median ratio of 0.9 for both
urban and rural areas in southern Africa, 0.94 for urban and 0.89
for rural areas in East Africa, 0.73 for urban and 0.59 for rural
areas in West and Central Africa, and 0.45 for urban and 0.87 for
rural areas in the Caribbean. The countries included in the
regional analysis, however, might not be entirely representative
of the respective regions, particularly in southern Africa where
some countries (Botswana, South Africa and Swaziland) were
excluded from the analysis because of the lack of urban and
rural specific data.
Applying correction factors to antenatal clinic-derived pre-
valence using either the probit-transformed median difference
or the untransformed median prevalence ratios produced
adjusted prevalence estimates that agreed well with the ‘‘gold
standard’’ population-based survey prevalences in both urban
and rural areas (table 2 and fig 2), with slightly better agreement
using the probit transformed median difference. A notable
exception was in rural areas of the Central African Republic
where the survey prevalence was 4.7%, the antenatal clinic-
derived prevalence was 15.4% and the adjusted antenatal clinic-
based estimates using the two correction factors were around
13%. Antenatal clinic surveillance data for Central African
Republic are sparse and 2002 was the last year for which
surveillance data were available. More recent data are therefore
required from antenatal clinics to obtain more accurate
estimates of HIV prevalence over time.
DISCUSSION
Comparison of HIV prevalence data from 26 countries with
generalised HIV epidemics show that unadjusted estimates of
adult HIV prevalence derived from antenatal clinic surveillance
are almost always higher than those from national population-
based household surveys.
While antenatal clinic surveillance and population-based
surveys both have strengths and weaknesses, the analysis of
data from the two sources provides complementary information
on both the point prevalence of HIV in countries as well as
information on epidemic trends. In particular, antenatal clinic-
based surveillance provides good data on epidemic trends over
time, while population-based surveys provide geographically
more representative estimates of adult HIV prevalence at a
particular point in time.
Analysis of population-based survey data in Ethiopia, Kenya,
Malawi, Tanzania and Uganda showed that when the popula-
tion was stratified to match the antenatal clinic population, the
HIV prevalence estimates were similar.
29 Studies also show that
non-response is unlikely to have a significant effect on HIV
prevalence measured from population-based surveys conducted
in countries with generalised epidemics.
91 3Only in countries
with high levels of non-response or large differences in HIV
prevalence between survey responders and non-responders is
the overall prevalence expected to be affected and in these
situations prevalence should be adjusted for prevalence among
non-responders.
91 2
Using national population-based surveys as ‘‘gold standard’’
for estimating adult prevalence, the results of this analysis show
that prevalence derived from antenatal clinic data have to be
adjusted downwards by about 20% (95% CI 10% to 30%) in
both urban and rural areas to obtain more accurate estimates of
national adult HIV prevalence. Applying the median difference
between probit-transformed survey and antenatal clinic-based
prevalence estimates to antenatal clinic-based prevalence in each
country resulted in predicted ‘‘gold standard’’ estimates that
were slightly more accurate than using the untransformed
median ratio of survey to antenatal clinic-based prevalence.
Countries in southern and East Africa where national pre-
valence is higher appear to require a slightly smaller adjustment
than those countries in West and Central Africa and in the
Caribbean with a relatively lower national prevalence.
Since 2001, UNAIDS has been adjusting antenatal clinic-
based prevalence estimates in rural areas, but not in urban areas,
downward by about 20% to account for the exclusion of sites in
remote areas from surveillance efforts.
5 However, the analysis
and correction factors derived in this paper indicate that
prevalence in both rural and urban areas should be adjusted
downwards by about 20%.
The analysis presented in this paper has been incorporated in
the UNAIDS estimates of HIV prevalence and impact in
countries with generalised epidemics for 2007, following
recommendations of the UNAIDS Reference Group on
Estimates, Modelling and Projections.
30 Using the latest version
of EPP,
17 antenatal clinic-based HIV prevalence curves were
adjusted as follows: prevalence curves for countries in which
national population-based surveys have been conducted were
calibrated to match the survey estimate for the year in which
the survey was conducted. For countries in which national
population-based surveys have not been conducted, antenatal
clinic-based prevalence curves in both urban and rural areas
were adjusted downwards on average by about 20%, according
to the probit-transformed correction factor described in this
paper. Adult HIV prevalence in sub-Saharan Africa in 2005 was
estimated at 6.1%.
6 The revised estimate for 2005 in this region
as estimated in 2007, using additional surveillance data and
revised methods, was 5.4% (epidemiology slides available on
www.unaids.org). In addition to having improved surveillance
data, the downward revision in estimates can be partly
explained by calibration of sentinel surveillance in a few
additional countries that have conducted household surveys
during this period (including Benin, Central African Republic,
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additional downward adjustment of prevalence in urban areas
in countries where household surveys have not been conducted.
A potential limitation of the analysis presented in this paper
relates to the quality of antenatal clinic surveillance in
countries. In the early stages of the epidemic, surveillance often
includes settings where there are known cases of HIV infection
and the analysis of data from these settings might lead to an
overestimation of the national prevalence. As surveillance
systems expand, more sentinel sites are included, often from
areas with lower prevalence than those initially included, and
prevalence might be reduced. In many countries included in this
analysis, including all countries in southern and East Africa, the
quality of surveillance is regarded as good, as shown elsewhere
in this issue.
31 However, in some countries in West and Central
Africa surveillance systems are only partially functioning and
expansion or improvement of the surveillance systems might
affect estimated prevalence and the correction factor needed to
adjust antenatal clinic-based prevalence. Furthermore, expan-
sion of treatment and other services might in future affect
antenatal clinic attendance patterns and estimated prevalence,
which could also affect the correction factor. It is therefore
recommended that the analysis presented in this paper be
updated on a regular basis as more data become available to
ensure the best possible estimation of the epidemic and its
impact.
Conclusion
A comparison of adult HIV prevalence obtained from national
population-based surveys and antenatal clinic surveillance
shows that unadjusted estimates derived from antenatal clinic
surveillance generally overestimate national adult HIV preva-
lence in countries with generalised epidemics. Providing that the
methodology used in national population-based surveys is
sound and reliable, and potential bias of survey non-response
is adjusted for, the population-based survey estimates can be
used to adjust antenatal clinic-based prevalence in countries
where such surveys have been conducted. In countries where
population-based surveys have not been conducted, the
recommendation, based on the analysis in this paper, is that
estimates of prevalence based on antenatal clinic surveillance in
both urban and rural areas should be adjusted downward by
about 20%.
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